Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2006-9-11
pubmed:abstractText
Targeting persistent tubercule bacilli has become an important challenge in the development of anti-tuberculous drugs. As the glyoxylate bypass is essential for persistent bacilli, interference with it holds the potential for designing new antibacterial drugs. We have developed kinetic models of the tricarboxylic acid cycle and glyoxylate bypass in Escherichia coli and Mycobacterium tuberculosis, and studied the effects of inhibition of various enzymes in the M. tuberculosis model.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10329645, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10523624, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10572116, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10871608, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10963578, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-11340206, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-11752250, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-11815613, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-12368431, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-12568740, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-14681416, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-14681452, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-14683609, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-1530563, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-15608210, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-15657047, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-15895072, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-16027371, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-2861202, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-6125497, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-6389540, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-6813266, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-7126549, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-8206824, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-9013556, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-9488673, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-9634230, http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-9927716
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1742-4682
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
27
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets.
pubmed:affiliation
Bioinformatics Centre, University of Pune, Pune-411007, India. vivek@bioinfo.ernet.in
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't